Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Castaralo Ltd. is currently prosecuting patents in the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action, which is being handled by 1 distinct examiner. This indicates a focused point of activity within its current patent filings. The involvement of 1 distinct art unit suggests that the pending matter is concentrated in a specific technical field within biotechnology. This lack of complexity in the current workload allows for a concentrated effort on this single pending matter at the USPTO.
The busiest examiner for Castaralo Ltd. is WRIGHT, SARAH C, who is responsible for 1 pending office action. Since there is only 1 pending action in the current data, this examiner is the sole individual reviewing the company's active applications. The presence of 1 distinct examiner and 1 distinct art unit indicates a very direct prosecution environment. Practitioners should note that the immediate outcome for this specific filing depends entirely on the interaction with this examiner. This streamlined structure ensures that the company's current patenting resources are focused on a single administrative channel.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, SARAH C | 1 | 41.6% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039989 | SOLUBLE SOLID FORM COSMETIC | WRIGHT, SARAH C | 77d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039989 | SOLUBLE SOLID FORM COSMETIC | WRIGHT, SARAH C | 77d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039989 | SOLUBLE SOLID FORM COSMETIC | WRIGHT, SARAH C | 1619 | §103§112 | Final Rejection | 77d | Pending | Jun 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial